Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATPAR: Ropivacaine for Diaphragmatic Function After Upper Abdominal Surgery
NCT02353702Phase 3Terminated
- Sponsor
- Rouen University Hospital
- Start
- Jul 2014
- Primary completion
- Jun 2017
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine hydrochloride liposomal suspension injection in Diaphragmatic dysfunction (DD), sponsored by Rouen University Hospital. Started Jul 2014; status: terminated.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
Diaphragmatic dysfunction (DD)
Beyond the preview
Go deeper on NCT02353702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02353702.